The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.
Brown Advisory Small-Cap Growth Inst BAFSX
- NAV / 1-Day Return 44.91 / −0.73 %
- Total Assets 1.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.980%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1.0 Mil
- Status Open
- TTM Yield —
- Turnover 29%
USD | NAV as of Apr 17, 2024 | 1-Day Return as of Apr 17, 2024, 10:17 PM GMT+0
Morningstar’s Analysis BAFSX
Will BAFSX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
First American Government Obligs Z | 4.67 | 107.1 Mil | Cash and Equivalents |
Bright Horizons Family Solutions Inc | 3.50 | 80.1 Mil | Consumer Cyclical |
ChampionX Corp | 2.51 | 57.5 Mil | Energy |
Casey's General Stores Inc | 2.46 | 56.4 Mil | Consumer Cyclical |
Prosperity Bancshares Inc | 2.33 | 53.4 Mil | Financial Services |
Bruker Corp | 2.17 | 49.8 Mil | Healthcare |
SPDR® S&P Biotech ETF | 2.11 | 48.4 Mil | — |
Neurocrine Biosciences Inc | 2.11 | 48.3 Mil | Healthcare |
NeoGenomics Inc | 2.09 | 47.9 Mil | Healthcare |
Encompass Health Corp | 2.04 | 46.9 Mil | Healthcare |